Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-11-29
1996-07-30
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 15, 530307, 530322, 530324, 530328, 530345, C07K 14585, A61K 823
Patent
active
055411592
ABSTRACT:
Peptide derivatives selected from (i) a calcitonin peptide and a LHRH antagonist peptide modified by at least one sugar residue and/or at least one short polyhydroxy compound or derivative, and (ii) a calcitonin peptide modified by at least one formyl and/or at least C.sub.3-5 alkyl attached to an amino group other than a N-terminal amino group, and (iii) a calcitonin peptide modified by a combination of said substituents, with the provisos that
REFERENCES:
patent: 3956260 (1976-05-01), Brugger et al.
patent: 4086221 (1978-04-01), Sakakibara et al.
Albert Rainer
Bauer Wilfried
Cardinaux Fran.cedilla.ois
Pless Janos
Honor Robert S.
Kassenoff Melvyn M.
McGovern Thomas O.
Sandoz Ltd.
Schain Howard E.
LandOfFree
Calcitonin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcitonin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcitonin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658597